vs
Side-by-side financial comparison of Sintx Technologies, Inc. (SINT) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Sintx Technologies, Inc. is the larger business by last-quarter revenue ($290.0K vs $240.0K, roughly 1.2× Vir Biotechnology, Inc.). Sintx Technologies, Inc. runs the higher net margin — -763.8% vs -67975.4%, a 67211.6% gap on every dollar of revenue. On growth, Sintx Technologies, Inc. posted the faster year-over-year revenue change (-46.5% vs -89.9%). Sintx Technologies, Inc. produced more free cash flow last quarter ($-2.4M vs $-167.9M). Over the past eight quarters, Sintx Technologies, Inc.'s revenue compounded faster (-35.0% CAGR vs -88.0%).
Sintx Technologies, Inc. is an advanced materials company specializing in R&D and manufacturing of high-performance silicon nitride and other technical ceramic products. It serves key segments including medical implants, aerospace & defense, industrial wear components, and electric vehicle applications, with core markets across North America, Europe and Asia-Pacific.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
SINT vs VIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $290.0K | $240.0K |
| Net Profit | $-2.2M | $-163.1M |
| Gross Margin | 64.8% | — |
| Operating Margin | -799.3% | -72267.9% |
| Net Margin | -763.8% | -67975.4% |
| Revenue YoY | -46.5% | -89.9% |
| Net Profit YoY | -30.7% | 23.7% |
| EPS (diluted) | $-0.50 | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $290.0K | — | ||
| Q3 25 | $208.0K | $240.0K | ||
| Q2 25 | $151.0K | $1.2M | ||
| Q1 25 | $369.0K | $3.0M | ||
| Q4 24 | $542.0K | $12.4M | ||
| Q3 24 | $799.0K | $2.4M | ||
| Q2 24 | $859.0K | $3.1M | ||
| Q1 24 | $687.0K | $56.4M |
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-3.5M | $-163.1M | ||
| Q2 25 | $-2.3M | $-111.0M | ||
| Q1 25 | $-2.3M | $-121.0M | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-6.2M | $-213.7M | ||
| Q2 24 | $-2.2M | $-138.4M | ||
| Q1 24 | $-886.0K | $-65.3M |
| Q4 25 | 64.8% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 37.7% | 99.1% | ||
| Q1 25 | 33.3% | — | ||
| Q4 24 | 71.6% | — | ||
| Q3 24 | 73.7% | 97.9% | ||
| Q2 24 | 73.9% | 98.3% | ||
| Q1 24 | 67.5% | 99.9% |
| Q4 25 | -799.3% | — | ||
| Q3 25 | -1613.0% | -72267.9% | ||
| Q2 25 | -1764.9% | -9754.3% | ||
| Q1 25 | -645.8% | -4602.5% | ||
| Q4 24 | -319.6% | — | ||
| Q3 24 | -802.0% | -9718.7% | ||
| Q2 24 | -315.5% | -5158.7% | ||
| Q1 24 | -465.4% | -142.0% |
| Q4 25 | -763.8% | — | ||
| Q3 25 | -1701.4% | -67975.4% | ||
| Q2 25 | -1535.1% | -9139.9% | ||
| Q1 25 | -621.1% | -3989.6% | ||
| Q4 24 | -312.7% | — | ||
| Q3 24 | -780.9% | -8979.7% | ||
| Q2 24 | -256.6% | -4500.1% | ||
| Q1 24 | -129.0% | -115.8% |
| Q4 25 | $-0.50 | — | ||
| Q3 25 | $-3.46 | $-1.17 | ||
| Q2 25 | $-0.91 | $-0.80 | ||
| Q1 25 | $-1.29 | $-0.88 | ||
| Q4 24 | $17.04 | — | ||
| Q3 24 | $-6.96 | $-1.56 | ||
| Q2 24 | $-3.61 | $-1.02 | ||
| Q1 24 | $-21.66 | $-0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9M | $796.1M |
| Total Assets | $9.5M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | — | ||
| Q3 25 | $6.3M | $497.8M | ||
| Q2 25 | $4.3M | $598.7M | ||
| Q1 25 | $6.5M | $790.9M | ||
| Q4 24 | $3.6M | $901.0M | ||
| Q3 24 | $4.8M | $909.0M | ||
| Q2 24 | $4.6M | $1.1B | ||
| Q1 24 | $5.8M | $1.1B |
| Q4 25 | $2.9M | — | ||
| Q3 25 | $4.1M | $796.1M | ||
| Q2 25 | $4.0M | $947.5M | ||
| Q1 25 | $6.1M | $1.0B | ||
| Q4 24 | $3.9M | $1.2B | ||
| Q3 24 | $5.6M | $1.2B | ||
| Q2 24 | $8.8M | $1.4B | ||
| Q1 24 | $9.9M | $1.5B |
| Q4 25 | $9.5M | — | ||
| Q3 25 | $11.4M | $1.0B | ||
| Q2 25 | $9.2M | $1.2B | ||
| Q1 25 | $11.4M | $1.3B | ||
| Q4 24 | $9.4M | $1.4B | ||
| Q3 24 | $11.3M | $1.5B | ||
| Q2 24 | $15.3M | $1.7B | ||
| Q1 24 | $17.6M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3M | $-167.6M |
| Free Cash FlowOCF − Capex | $-2.4M | $-167.9M |
| FCF MarginFCF / Revenue | -822.8% | -69952.9% |
| Capex IntensityCapex / Revenue | 14.5% | 132.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $-2.5M | $-167.6M | ||
| Q2 25 | $-2.4M | $-120.2M | ||
| Q1 25 | $-1.3M | $-78.1M | ||
| Q4 24 | $-1.1M | $-446.4M | ||
| Q3 24 | $-2.6M | $-171.5M | ||
| Q2 24 | $-2.2M | $-77.8M | ||
| Q1 24 | $-2.7M | $-109.4M |
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-2.6M | $-167.9M | ||
| Q2 25 | — | $-122.8M | ||
| Q1 25 | $-1.4M | $-79.7M | ||
| Q4 24 | $-1.3M | $-453.7M | ||
| Q3 24 | $-2.6M | $-174.2M | ||
| Q2 24 | $-2.6M | $-78.5M | ||
| Q1 24 | $-2.9M | $-111.3M |
| Q4 25 | -822.8% | — | ||
| Q3 25 | -1250.5% | -69952.9% | ||
| Q2 25 | — | -10111.8% | ||
| Q1 25 | -368.6% | -2630.1% | ||
| Q4 24 | -234.3% | -3666.2% | ||
| Q3 24 | -323.0% | -7321.3% | ||
| Q2 24 | -299.7% | -2553.3% | ||
| Q1 24 | -423.1% | -197.4% |
| Q4 25 | 14.5% | — | ||
| Q3 25 | 40.4% | 132.1% | ||
| Q2 25 | 0.0% | 209.1% | ||
| Q1 25 | 16.0% | 53.7% | ||
| Q4 24 | 26.9% | 59.0% | ||
| Q3 24 | 1.4% | 116.3% | ||
| Q2 24 | 41.8% | 21.7% | ||
| Q1 24 | 25.3% | 3.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
